Results 91 to 100 of about 181,406 (245)

Acute lymphoblastic leukemia of childhood presenting as aplastic anemia: report of two cases

open access: yesRevista Brasileira de Hematologia e Hemoterapia, 2012
Acute lymphoblastic leukemia is the most common malignancy in pediatric patients; its diagnosis is usually easy to establish as malignant lymphoblasts invade the bone marrow and peripheral blood.
Laura Villarreal-Martínez   +4 more
doaj   +1 more source

Clonal Dynamics of GPI‐Deficient Cells in Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH): A Retrospective Follow‐Up Analysis

open access: yesEuropean Journal of Haematology, EarlyView.
ABSTRACT This retrospective, single‐center study aimed to characterize clonal dynamics of GPI‐deficient cells in patients with paroxysmal nocturnal hemoglobinuria (PNH) or PNH/aplastic anemia (AA) syndrome using multiparameter flow cytometry including FLAER.
Sandra M. Frey   +6 more
wiley   +1 more source

Current approach for the diagnosis of Aplastic Anemia.

open access: yes, 2016
The current approach for the diagnosis of aplastic anemia is based on morphology and cytogenetics of hematopoietic cells. The morphological characteristics and similarities with other bone marrow failures disorders represent a real challenge in the ...
Rovó, Alicia, Tichelli, Andre
core  

Deep intronic ANK1 variants causing pseudo‐exon inclusion in hereditary spherocytosis: Whole‐genome sequencing and functional assessment

open access: yes
British Journal of Haematology, EarlyView.
Victor Marin   +8 more
wiley   +1 more source

Expert Consensus on the Diagnosis and Monitoring of Paroxysmal Nocturnal Hemoglobinuria (PNH): An Algorithmic Approach in an Era of New Treatments

open access: yesEuropean Journal of Haematology, EarlyView.
ABSTRACT Paroxysmal nocturnal hemoglobinuria (PNH) is a rare hematologic disorder caused by a defect of glycosylphosphatidyl‐anchored proteins, leading to an uncontrolled complement‐mediated hemolysis. The advent of complement inhibitors in clinical practice radically changed patients' outcomes and survival.
Bruno Fattizzo   +8 more
wiley   +1 more source

Long‐term efficacy and safety of romiplostim plus immunosuppressive therapy as first‐line treatment in patients with aplastic anaemia: 2‐year interim analysis of observational study of two clinical trials

open access: yes
British Journal of Haematology, EarlyView.
Jong Wook Lee   +19 more
wiley   +1 more source

Exome sequencing identifies MPL as a causative gene in familial aplastic anemia

open access: yesHaematologica, 2012
The primary cause of aplastic anemia remains unknown in many patients. The aim of this study was to clarify the genetic cause of familial aplastic anemia.
Amanda J. Walne   +7 more
doaj   +1 more source

Thrombocytopenia in Pregnancy: A 5‐Year Analysis of Characteristics and Practices From a Tertiary Academic Center

open access: yesInternational Journal of Laboratory Hematology, EarlyView.
ABSTRACT Background Moderate‐to‐severe thrombocytopenia (platelet count < 100 × 109/L) occurs in fewer than 1% of pregnancies, posing management challenges, particularly surrounding eligibility for neuraxial anesthesia. Although recent anesthesia guidelines recommend a platelet threshold ≥ 70 × 109/L, outcomes data applying these recommendations in ...
Mackenzie E. Lemieux, Ming Y. Lim
wiley   +1 more source

Aplastic anemia during pregnancy: a review of obstetric and anesthetic considerations

open access: yes, 2018
Efrain Riveros-Perez,1 Amy C Hermesch,2 Linda A Barbour,3 Joy L Hawkins4 1Department of Anesthesiology and Perioperative Medicine, Medical College of Georgia, Augusta University, Augusta, GA, 2Maternal Fetal Medicine, 3Obstetrics and Gynecology ...
Riveros-Perez E   +3 more
core  

Etiopathogenesis of aplastic anemia in children: a case control study [PDF]

open access: yes, 2016
Background: Aplastic anemia is not an infrequent clinical syndrome that we encounter. In about two thirds of cases of aplastic anemia it is not possible to identify any likely cause.
Verma, Sanjeev Kumar   +5 more
core   +1 more source

Home - About - Disclaimer - Privacy